Patent details
EP4086264 Title: ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
Basic Information
- Publication number:
- EP4086264
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP221664790
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
- French Title of Invention:
- PROMÉDICAMENTS DE L'ALVOCIDIB À BIODISPONIBILITÉ AUGMENTÉE
- German Title of Invention:
- ALVOCIDIB-PRODRUGS MIT ERHÖHTER BIOVERFÜGBARKEIT
- SPC Number:
Dates
- Filing date:
- 18/05/2016
- Grant date:
- 25/10/2023
- EP Publication Date:
- 09/11/2022
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 25/10/2023
- EP B1 Publication Date:
- 25/10/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 18/05/2024
- Expiration date:
- 18/05/2036
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 18/10/2023
- Name:
- Sumitomo Pharma Oncology, Inc.
- Address:
- 84 Waterford Drive, Marlborough, MA 01752, United States (US)
Inventor
1
- Name:
- Bearss, David J.
- Address:
- United States (US)
2
- Name:
- Siddiqui-Jain, Adam
- Address:
- United States (US)
Priority
- Priority Number:
- 201562163188 P
- Priority Date:
- 18/05/2015
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C07F 9/12; A61K 31/661; A61P 35/00;
Publication
European Patent Bulletin
- Issue number:
- 202343
- Publication date:
- 25/10/2023
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|